Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

320 Views

Z5. COVID-19 Complications, co-infections, and clinical outcomes

Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes

(P-1906) Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario, Canada.

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Caroline Kassee, MPH

Epidemiologist
Sinai Health System
Toronto, Ontario, Canada

Co-Author(s)

MK

Moe H. Kyaw, PhD

Pfizer
New York, New York, United States
ZZ

Zoe Zhong, PhD (she/her/hers)

Clinical research manger
Sinai Health System, University of Toronto
Toronto, Ontario, Canada
AS

Altynay Shigayeva, PhD

Epidemiologist
Sinai health
Toronto, Ontario, Canada
CM

Catherine Martin, PhD

Pfizer Inc.
Paris, Ile-de-France, France
LF

Lubna Farooqi, MBBS

Sinai Health System, University of Toronto
Toronto, Ontario, Canada
BC

Brenda Coleman, PhD

Sinai Health System, University of Toronto
Toronto, Ontario, Canada
WG

Wayne Gold, MD

Professor
University of Toronto
Toronto, ON, Canada
CK

Christopher Kandel, MD, PhD

Clinician Scientist
Toronto East General Hospital
Toronto, Ontario, Canada
MM

Maria Major, B.Sc., M.P.H.

Field Medical Advisor
Pfizer Canada
Kirkland, QC, Canada
SM

Samira Mubareka, MD

Scientist
Sunnybrook Health Sciences Centre, University of Toronto
Toronto, Ontario, Canada
SV

Srinivas Valluri, PhD

Pfizer Inc
New York, New York, United States
John M. McLaughlin, PhD

Sr. Director, Clinical Epidemiology
Pfizer
Collegeville, PA, United States
AM

Allison McGeer, MD

Dr.
Mt. Sinai Hospital
Toronto, Ontario, Canada